Skip to content

Comparison between local excision and radical excision in mid-to-low rectal cancer patients who revealed good response after preoperative chemoradiotherapy

Verification of local excision in mid-to-low rectal cancer patients who revealed clinically total or near-total regression after preoperative chemoradiotherapy

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CRIS
Registry ID
KCT0002579
Enrollment
140
Registered
2017-12-01
Start date
2017-03-29
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : Local excision will bee performed through all kind of transanal approach including transanal excision and transanal minimal invasive surgery. Radical excision includes open, laparo

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -pathologically-proven adenocarcinoma below 8 cm from the anal verge -mrTRG 1 (radiologically complete remission) or mrTRG 2 (radiologically near-complete remission, only remained fibrosis) after Preoperative chemoradiotherapy and confirmed by multi-disciplinary team or central adjudification. -more than 20 years-old and below 80 years-old -Good performance status (ECOG performance status 2 or less) -agreed with this study

Exclusion criteria

Exclusion criteria: -pathologically-proven adenocarcinoma above 8 cm from the anal verge -microperforated tumor before preoperative chemoradiotherapy -previous history of radiotherapy -presence of distant metastasis, other malignancies, or synchronous colorectal cancer -history of treatment for other malignancies -included other study related to surgical method -pregnancy or feeding

Design outcomes

Primary

MeasureTime frame
Postoperative complication rate

Secondary

MeasureTime frame
recurrence rate and survival rate; quality of life including defecatory function;Accuracy of mrTRG (tumor regression) comapred with pathologic TRG;Analysis of effectiveness between local excision and total mesorectal excision

Countries

Korea, Republic of

Contacts

Public ContactJONG LYUL LEE

Asan Medical Center

iamleejong@hotmail.com+82-2-3010-1732

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 21, 2026